1st Quarter - Report

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$209,061
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FY14 and FY 15 Labor-HHS Appropriations Bill, 340B Drug Discount Program Congressional Oversight, HRSA's expected 2014 Mega-Rule on 340B, cancer drug reimbursement, hospital reimbursement issues

LobbyistCovered position, as disclosed
JOHN COSTER —
JEFFREY IRVING DAVIS —
KATHRYN DIBITETTO —
GREG DOGGETT —
TED SLAFSKY —
LIAM STEADMAN —
MAUREEN TESTONI —

Contacted: SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.